Table of Contents

2019-2024 Global Pharmaceutical Intermediates Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Pharmaceutical Intermediates Consumption 2014-2024
  • 2.1.2 Pharmaceutical Intermediates Consumption CAGR by Region
• 2.2 Pharmaceutical Intermediates Segment by Type
  • 2.2.1 GMP
  • 2.2.2 Non-GMP
• 2.3 Pharmaceutical Intermediates Consumption by Type
  • 2.3.1 Global Pharmaceutical Intermediates Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Pharmaceutical Intermediates Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Pharmaceutical Intermediates Sale Price by Type (2014-2019)
• 2.4 Pharmaceutical Intermediates Segment by Application
  • 2.4.1 Antibiotics
  • 2.4.2 Antipyretic Analgesics
  • 2.4.3 Vitamins
  • 2.4.4 Others
• 2.5 Pharmaceutical Intermediates Consumption by Application
  • 2.5.1 Global Pharmaceutical Intermediates Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Pharmaceutical Intermediates Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Pharmaceutical Intermediates Sale Price by Application (2014-2019)

3 Global Pharmaceutical Intermediates by Players

• 3.1 Global Pharmaceutical Intermediates Sales Market Share by Players
  • 3.1.1 Global Pharmaceutical Intermediates Sales by Players (2017-2019)
  • 3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Players (2017-2019)
• 3.2 Global Pharmaceutical Intermediates Revenue Market Share by Players
  • 3.2.1 Global Pharmaceutical Intermediates Revenue by Players (2017-2019)
  • 3.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Players (2017-2019)
• 3.3 Global Pharmaceutical Intermediates Sale Price by Players
• 3.4 Global Pharmaceutical Intermediates Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Pharmaceutical Intermediates Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Pharmaceutical Intermediates Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Pharmaceutical Intermediates by Regions

• 4.1 Pharmaceutical Intermediates by Regions
  • 4.1.1 Global Pharmaceutical Intermediates Consumption by Regions
  • 4.1.2 Global Pharmaceutical Intermediates Value by Regions
• 4.2 Americas Pharmaceutical Intermediates Consumption Growth
• 4.3 APAC Pharmaceutical Intermediates Consumption Growth
• 4.4 Europe Pharmaceutical Intermediates Consumption Growth
• 4.5 Middle East & Africa Pharmaceutical Intermediates Consumption Growth

5 Americas

• 5.1 Americas Pharmaceutical Intermediates Consumption by Countries
  • 5.1.1 Americas Pharmaceutical Intermediates Consumption by Countries (2014-2019)
  • 5.1.2 Americas Pharmaceutical Intermediates Value by Countries (2014-2019)
• 5.2 Americas Pharmaceutical Intermediates Consumption by Type
• 5.3 Americas Pharmaceutical Intermediates Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Pharmaceutical Intermediates Consumption by Countries
  • 6.1.1 APAC Pharmaceutical Intermediates Consumption by Countries (2014-2019)
  • 6.1.2 APAC Pharmaceutical Intermediates Value by Countries (2014-2019)
• 6.2 APAC Pharmaceutical Intermediates Consumption by Type
• 6.3 APAC Pharmaceutical Intermediates Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Pharmaceutical Intermediates by Countries
  • 7.1.1 Europe Pharmaceutical Intermediates Consumption by Countries (2014-2019)
  • 7.1.2 Europe Pharmaceutical Intermediates Value by Countries (2014-2019)
• 7.2 Europe Pharmaceutical Intermediates Consumption by Type
• 7.3 Europe Pharmaceutical Intermediates Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Pharmaceutical Intermediates by Countries
  • 8.1.1 Middle East & Africa Pharmaceutical Intermediates Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Pharmaceutical Intermediates Value by Countries (2014-2019)
• 8.2 Middle East & Africa Pharmaceutical Intermediates Consumption by Type
• 8.3 Middle East & Africa Pharmaceutical Intermediates Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Pharmaceutical Intermediates Distributors
• 10.3 Pharmaceutical Intermediates Customer

11 Global Pharmaceutical Intermediates Market Forecast

• 11.1 Global Pharmaceutical Intermediates Consumption Forecast (2019-2024)
• 11.2 Global Pharmaceutical Intermediates Forecast by Regions
  • 11.2.1 Global Pharmaceutical Intermediates Forecast by Regions (2019-2024)
  • 11.2.2 Global Pharmaceutical Intermediates Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Pharmaceutical Intermediates Forecast by Type
• 11.8 Global Pharmaceutical Intermediates Forecast by Application

12 Key Players Analysis

• 12.1 Lonza
  • 12.1.1 Company Details
  • 12.1.2 Pharmaceutical Intermediates Product Offered
  • 12.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Lonza News
• 12.2 Catalent
  • 12.2.1 Company Details
  • 12.2.2 Pharmaceutical Intermediates Product Offered
  • 12.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Catalent News
• 12.3 Patheon
  • 12.3.1 Company Details
  • 12.3.2 Pharmaceutical Intermediates Product Offered
  • 12.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Patheon News
• 12.4 Jubilant
  • 12.4.1 Company Details
  • 12.4.2 Pharmaceutical Intermediates Product Offered
  • 12.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Jubilant News
• 12.5 Granules
  • 12.5.1 Company Details
  • 12.5.2 Pharmaceutical Intermediates Product Offered
  • 12.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Granules News
• 12.6 Ganesh
  • 12.6.1 Company Details
  • 12.6.2 Pharmaceutical Intermediates Product Offered
  • 12.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Ganesh News
• 12.7 Chemcon
  • 12.7.1 Company Details
  • 12.7.2 Pharmaceutical Intermediates Product Offered
  • 12.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Chemcon News
• 12.8 BASF
  • 12.8.1 Company Details
  • 12.8.2 Pharmaceutical Intermediates Product Offered
  • 12.8.3 BASF Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 BASF News
• 12.9 Porton
  • 12.9.1 Company Details
  • 12.9.2 Pharmaceutical Intermediates Product Offered
  • 12.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Porton News
• 12.10 Lianhetech
  • 12.10.1 Company Details
  • 12.10.2 Pharmaceutical Intermediates Product Offered
  • 12.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Lianhetech News
• 12.11 ABA Chem
• 12.12 Tianma
• 12.13 Jiujiujiu
• 12.14 Alpha
• 12.15 Jiuzhou
• 12.16 Yongtai

13 Research Findings and Conclusion

Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
This industry is affected by the economy and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to rising environment standards, especially in underdevelopment regions that have a large population and fast economic growth, the need will increase.
The industry is a high-technology and high-profit industry, the research team maintain a very optimistic attitude. It is suggested that the new enterprises to enter the field.
We tend to believe this industry now is close to mature, and the consumption increasing degree will show a smooth curve. On product prices, the slow downward trend in recent years will maintain in the future, as competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.

According to this study, over the next five years the Pharmaceutical Intermediates market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pharmaceutical Intermediates business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Intermediates market by product type, application, key manufacturers and key regions and countries.

This study considers the Pharmaceutical Intermediates value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
GMP
Non-GMP
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Antibiotics
Antipyretic Analgesics
Vitamins
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Lonza
Catalent
Patheon
Jubilant 
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pharmaceutical Intermediates consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pharmaceutical Intermediates market by identifying its various subsegments.
Focuses on the key global Pharmaceutical Intermediates manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pharmaceutical Intermediates with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pharmaceutical Intermediates submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.